World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01211223
Date of registration: 28/09/2010
Primary sponsor: University of Chile
Public title: Effects of the Variation in the Time of Systemic Administration of Metronidazole and Amoxicillin Associated to the Non-surgical Therapy of Chronic Periodontitis. Metro + Amoxi
Scientific title: Effects of the Variation in the Time of Systemic Administration of Metronidazole and Amoxicillin Associated to the Non-surgical Therapy of Chronic Periodontitis.
Date of first enrolment: January 2010
Target sample size: 36
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01211223
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment  
Countries of recruitment
Chile
Contacts
Name:   Jorge Gamonal, Professor
Address: 
Telephone: 56-2-9721164
Email: jgamonal@uchile.cl
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- a) age of 35 years old or more, b) at least 3 molars in the mouth, c) at least one
site in three of the four quadrants with clinical attachment loss = 3mm; d) at least
4 sites in different teeth with probing depth and clinical attachment level = 6mm and
bleeding on probing and at least 14 tooth present in the mouth

Exclusion Criteria:

- a) previous professional root planning; b) systemic/topic antibiotic or
antiinflammatory treatment, at least 6 months prior to the initiation of the study;
c) inmunosupresion or need for antibiotic coverage for routine dental therapy; d)
systemic condition that could affect the progression of periodontal disease
(diabetes); e) pregnancy or lactation; e) allergy or intolerance to metronidazole or
amoxicillin; f) smokers



Age minimum: 35 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Chronic Periodontitis
Clinical and Microbiological Effects
Intervention(s)
Drug: Administration of Metronidazole plus Amoxicillin
Primary Outcome(s)
- Mean change in clinical attachment level (CAL) [Time Frame: 12 months]
Secondary Outcome(s)
- Mean change in probing pocket depths (PD) [Time Frame: 12 months]
Secondary ID(s)
Facultad Odontologia, U Chile
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history